Literature DB >> 21412934

Chikungunya virus: host pathogen interaction.

Sunit Kumar Singh1, Salini Krishnan Unni.   

Abstract

Chikungunya is a re-emerging arthropod-borne viral disease caused by Chikungunya virus (CHIKV) belonging to the Togaviridae family of genus Alphavirus. It is a virus with a single stranded, positive sense RNA, as its genome. It is maintained in a sylvatic and urban cycle involving humans and the mosquito species Aedes aegypti and Aedes albopictus. It has garnered the attention of scientists in the past 5-6 years due to the massive outbreaks in the Indian Ocean region in 2005-2006. It has a major health impact on humans as it causes fever, rashes, arthralgia and myalgia. Polyarthralgia is the most important feature of CHIKV infection which primarily affects the small joints of the wrists and fingers along with the large joints like shoulders and knees. Currently, there are no vaccines or treatment regimens available for CHIKV infection. The molecular mechanism underlying the chronic polyarthralgia observed in patients is not well understood. In this review we have summarized the CHIKV organization, replication, epidemiology, clinical manifestations and pathogenesis with emphasis on the arthralgia.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21412934     DOI: 10.1002/rmv.681

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  19 in total

Review 1.  Chikungunya fever: a threat to global public health.

Authors:  Raíza Nara Cunha Moizéis; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Marcos da Matta Guedes; Hannaly Wana Bezerra Pereira; Daniel Carlos Ferreira Lanza; Judson Welber Veríssimo de Azevedo; Josélio Maria de Araújo Galvão; José Veríssimo Fernandes
Journal:  Pathog Glob Health       Date:  2018-05-28       Impact factor: 2.894

Review 2.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

3.  Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.

Authors:  Larisa Ivanova; Kai Rausalu; Maksim Ošeka; Dzmitry G Kananovich; Eva Žusinaite; Jaana Tammiku-Taul; Margus Lopp; Andres Merits; Mati Karelson
Journal:  ACS Omega       Date:  2021-04-14

4.  Two disciplines, one priority: the seamless integration of human and veterinary microbiology is urgent.

Authors:  Colin R Howard
Journal:  Emerg Microbes Infect       Date:  2012-08       Impact factor: 7.163

5.  Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates.

Authors:  Chonticha Saisawang; Pornpan Sillapee; Kwanhathai Sinsirimongkol; Sukathida Ubol; Duncan R Smith; Albert J Ketterman
Journal:  Biosci Rep       Date:  2015-04-22       Impact factor: 3.840

Review 6.  Antiviral perspectives for chikungunya virus.

Authors:  Deepti Parashar; Sarah Cherian
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

7.  Chikungunya virus glycoproteins pseudotype with lentiviral vectors and reveal a broad spectrum of cellular tropism.

Authors:  Dakang Hu; Jin Zhang; Hua Wang; Shuangchun Liu; Lianhua Yu; Lingfen Sun; Ying Qu
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 8.  The role of environmental variables on Aedes albopictus biology and chikungunya epidemiology.

Authors:  Joanna Waldock; Nastassya L Chandra; Jos Lelieveld; Yiannis Proestos; Edwin Michael; George Christophides; Paul E Parham
Journal:  Pathog Glob Health       Date:  2013-07       Impact factor: 2.894

9.  Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts.

Authors:  Sakthi Priya Selvamani; Ritu Mishra; Sunit K Singh
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.

Authors:  L Delang; C Li; A Tas; G Quérat; I C Albulescu; T De Burghgraeve; N A Segura Guerrero; A Gigante; G Piorkowski; E Decroly; D Jochmans; B Canard; E J Snijder; M J Pérez-Pérez; M J van Hemert; B Coutard; P Leyssen; J Neyts
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.